AstraZeneca wants you to have support options available

*To be eligible, patients must be a resident of the United States or Puerto Rico and have commercial health insurance that covers medication costs for IMFINZI, but not the full cost to the patient. Patients are ineligible if prescriptions are paid by any state or other federally funded programs, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA or TRICARE, or where prohibited by law. Additional restrictions may apply. The IMFINZI Patient Savings Program covers the cost of IMFINZI and up to $100 administration cost per infusion, per drug, and does not cover costs for office visits, or any other associated costs. Offer is invalid for claims and transactions more than 365 days from the date of service. Individual costs and benefit design may vary by plan. Costs to patients may vary by plan. Please consult with individual plan for specific information.

^†Patients who are residents of Massachusetts and Rhode Island are not eligible for infusion administration assistance. Patients are responsible for any cost associated with the infusion above the $100 per infusion assistance provided by the program.